Rapid referral for headache management from Emergency Department to Headache Centre: four years data

DOI: https://doi.org/10.21203/rs.2.21980/v1

Abstract

Background

Headache is one of the most common reason for medical consultation to emergency department (ED). Inappropriate use of ED for non-urgent conditions is a problem in terms of crowding emergency facilities, unnecessary testing and treatment, increased medical bills, burden on medical service providers and weaker patient-primary care provider relationships. The aim of this study was to analyzed the different steps of the ED management of patients with headache to detect those deficiencies that can be overcome by a prompt referral to a headache clinic.

Methods

The study is a retrospective analysis of the electronic medical records (EMRs) of patients discharged from an academic ED between 1 January 2015 and 31 December 2018 and referred to the tertiary level headache centre of the same hospital. We analyzed all the aspects related to the permanence in ED and we also assessed if there was a concordance between ED diagnosis and ours.

Results

Among our sample of 244 patients, 76.2% were admitted as green tag, 75% underwent a head computed tomography, 19.3% received neurological consultation, 43% did not receive any pharmacological treatment and 62.7% still had headache at discharge. Length in ED stay was associated with the complaint of the first aura ever (p = 0.014) and if patients received consultations (p < 0.001). Concordance analysis shown a significant moderate agreement only for the diagnosis of migraine and only between triage and headache centre.

Conclusions

The majority of patients who went to the ED complaining of headache received the same therapy regardless of their diagnosis and in many cases the headache had not yet resolved at the time of discharge. Given the several shortcomings of ED management of headaches, a rapid referral to the headache centre is of primary importance to help the patient obtain a definite diagnosis and adequate treatment.

Introduction

Headache is one of the most common symptoms and an important reason for medical consultation and presentation to emergency departments (EDs). Indeed, of all patients who visit EDs, up to 4.5% report that non-traumatic headache is their main complaint [1]. The third edition of the International Classification of Headache Disorders (ICHD-III) distinguishes secondary forms, in which headache is a symptom, from primary headaches which include migraine (with or without aura), tension-type headache and the group of trigeminal autonomic cephalalgias (TACs) for which cluster headache counts for the majority [2]. Migraine alone is the world’s second leading cause of years of life lived with disability [3] and chronic migraine (CM) patients, who have ≥15 headache days per month, are more likely to have a higher disability, lower quality of life and greater use of healthcare resources than episodic migraine (EM) patients [4, 5].

In the ED, as in the general population, primary headache disorders are much more common than secondary disorders and it can be challenging for ED doctors to distinguish the few patients with potentially life-threatening headaches among the vast majority with benign headaches [6]. A primary headache is diagnosed in 58-81.2% of patients entering the ED with headache and, as regards the specific diagnosis of primary headache, migraine is the main condition, which represent 17–64% of cases [710]. While most headaches have benign etiology and are self-limiting, up to 5% have a serious and life-threatening cause (e.g., subarachnoid hemorrhage) that requires immediate medical attention [11, 12].

Inappropriate use of ED for non-urgent conditions is a problem in terms of crowding emergency facilities, unnecessary testing and treatment, increased medical bills, burden on medical service providers and weaker patient-primary care provider relationships. Studies evaluating this phenomenon found that inability to take time off from school or work during the day, the ease of use of emergency care and the non-necessity for an appointment are indicated as a reason for their consultation by a significant percentage of patients, suggesting that inappropriate use of ED could be a matter of personal convenience [13, 14]. An observational study investigated the factors associated with ED visits for migraine and found that the most common reason for visiting ED was a perceived emergency condition or referral by a physician (33.3%) [15]. The other most commonly cited reasons concerned timely access to care, either because the medical office was closed (20%) or because patients could not get an appointment early enough (11%), or because they didn’t have a doctor or nowhere else to go (9%) [16]. Studies conducted in other countries suggest that migraine is under- or misdiagnosed and, consequently, patients are often undertreated or receiving inadequate care when consulting an ED [8, 16, 17].

There is a close collaboration with ED in our hospital and all patients with headache complaints after discharge can be referred to our clinic and visited within 36 hours.

Given the lack of Italian studies on patients presenting with headache to ED, we conducted a study to determine the demographic and clinical characteristics of these patients, to establish the frequency and accuracy of the diagnosis of migraine and to describe the treatment they received and their follow-up in our headache centre.

Methods

The study is a retrospective analysis of the electronic medical records (EMRs) of patients who presented to the academic ED of Azienda Ospedaliera Sant’Andrea, between 1 January 2015 and 31 December 2018 with a chief compliant of headache and who, after discharge, were referred to the Regional Referral Headache Centre, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome.

Data collection

The data analyzed included basic demographic information, presentation time, priority assessment and diagnosis of admission by the hospital triage nurse, door-to-doctor time and the length of stay in ED, life parameters, diagnostic investigations, specialist consultations, administration of treatments and discharge diagnosis. We also assessed the time elapsed between discharge from the ED and the first visit to our headache center and whether there was a concordance between the diagnosis of discharge from the emergency room and ours.

For what concern the priority of admission, our ED uses an advanced triage system that involves a color-coding scheme using white, green, yellow and red tags to defining conditions on increasing level of severity:

For the analysis of the vital signs, we defined elevated blood pressure (BP) as follows: systolic BP (SBP) ≥140 mm Hg or diastolic BP (DBP) ≥90 mm Hg [18].

The diagnosis in our headache centre was made on the base of the beta version or the final version of the ICHD-III depending on the year when the visit was performed [2, 19].

Statistical analyses

Descriptive analysis of the sample characteristics was performed. Categorical data was summarized by numbers and percentages, continuous data by mean and standard deviation. The association between total time in emergency department and follow-up at the headache centre was evaluated by Mann-Whitney tests. The concordance between primary headaches diagnosis was assessed using the Cohen Kappa coefficient (κ). The significance level was set at 0.05 (always corrected if necessary). All analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).

 

 

Results

Demographics and clinical characteristics of the study population

Demographic and clinical characteristics of patients treated in the emergency department in Table 1. The sample analyzed was composed of 244 patients, 192 (78.7%) women and 52 (21.3%) men, aged between 14 and 89 years and an average of 40.7 years. After the evaluation of the general conditions, the triage nurses coded a patient (0.4%) as a white tag, 186 (76.2%) as a green tag, 56 (23.0%) as a yellow tag and a patient (0.4%) as a red tag. Medical history was negative for any conditions in 157 (64.3%) patients. Among several conditions, the most frequent were hypertension (in 11.1% of patients), psychiatric disorders (in 8.6% of patients) and thyroid diseases (in 7.0% of patients). Patients presented to the ED after a mean of 1.9 days after the onset of the headache for which they required assistance. The appearance of the aura was the primary reason for ED consultation for 40 (16.4) patients and for 16 (40%) of them it was the first aura of their life. The average vital signs values for the entire sample of patients were in the normal range: systolic pressure was 130 mmHg (range: 100–190), diastolic pressure was 77 mmHg (range: 50–111), heart rate was 78 bpm (range: 39–116), temperature was 36.6ºC (range: 35.9–38) and oxygen saturation was 98% (range: 94–100).

Table 1
Demographic and clinical characteristics of patients treated in the emergency department
Demographics
 
age (years) (SD)
40.7 (16.3)
sex (female)
192 (78.7)
Medical history
 
negative
157 (64.3)
hypertension
27 (11.1)
psychiatric disorders
21 (8.6)
thyroid disorders
17 (7.0)
hematologic disorders
10 (4.1)
dyslipidemia
9 (3.7)
DM type 2
8 (3.3)
cerebrovascular diseases
7 (2.9)
COPD/asthma
4 (1.6)
ischemic heart disease
3 (1.2)
solid tumor
3 (1.2)
Time of ED presentation
 
08:00–15:59
147 (60.3)
16:00–23:59
79 (32.4)
00:00–07:59
18 (7.4)
Headache onset
 
days bedore ED visit
1.9 (5.7)
Triage codes
 
white
1 (0.4)
green
186 (76.2)
yellow
56 (23.0)
red
1 (0.4)
Vital signs
 
systolic BP (mmHg)
130 (16.9)
diastolic BP (mmHg)
77 (10.6)
heart rate (bpm)
78 910.60
temperature (°C)
36.6
oxygen saturation (%)
98 (1.4)
Aura
 
reason to access ED
40 (16.4)
first aura in their life
16 of 40 (40.0)
ED times in min, mean (SD)
 
door-to-doctor time
139 (118.4)
time of care
241 (269.8)
ED length of stay
381 (307.7)
DM: diabetes mellitus; ED: emergency department; SD: standard deviation

Diagnosis of headache in the emergency department

Table 2 summarized the changes in diagnoses in relation to the clinical evaluation setting. We found eleven different admission diagnoses assessed by triage nurse. The three most common diagnoses were headache (63.6%), migraine without aura (9.0%) and ophthalmic headache (6.6%). ED physicians used less diagnoses (four) and the most frequent was headache (52.5%).

Table 2
Changes in diagnoses in relation to the clinical evaluation setting
DIAGNOSIS
TRIAGE nurse
ED doctor
Headache centre
Concordance TRIAGE - headache centre
 
(244 patients)
(244 patients)
(240 patients)
(κ; p - value)
Headache
155 (63.6)
128 (52.5)
--
 
Migraine without aura
22 (9.0)
82 (33.6)
140 (57.4)
0.581 ; p < 0.001
Migraine with aura (ophthalmic headache)
16 (6.6)
--
34 (13.9)
0.032 ; p = 0.586
Tension-type headache
--
--
32 (13.1)
--
Chronic migraine
--
--
35 (14.3)
--
Medication overuse headache
--
--
31 (12.7)
--
Cluster hedache
2 (0.8)
2 (0.8)
7 (2.9)
-0.013 ; p = 0.001
Other TACs
--
--
1 (0.4)
--
Trigeminal neuralgia
8 (3.3)
--
3 (1.2)
--
Headache attributed to trauma
5 (2.1)
32 (13.1)
8 (3.3)
--
Sinusitis
--
--
2 (0.8)
--
Headache attributed to cranial and/or cervical vascular disorder
16 (6.6)
--
6 (2.5)
--
Headache and arterial hypertension
10 (4.1)
--
5 (2.0)
--
Headache and systemic infection
6 (2.5)
--
1 (0.4)
--
Headache and anxiety disorder
3 (1.2)
--
--
--
Cervicogenic headache
1 (0.4)
--
--
--
TACs: trigeminal autonomic cephalalgias
Triage nurses used the definition “ophthalmic headache” to indicate the diagnosis of “migraine with aura”.
The concordance between primary headaches diagnosis was assessed using the Cohen Kappa coefficient (κ). The significance level was set at 0.05.
There was not agreement between diagnoses made by ED physicians and headache centre.

Headache investigations received in the emergency department

Most patients performed complementary examinations for diagnosis (Table 3). The most common investigation was head computed tomography (CT) required for 183 (75%) patients. A patient with a known diagnosis of migraine refused to undergo CT. Of the 182 CT scans performed 170 (93.4%) were negative and 13 (7.1%) had findings that were all considered incidental: sphenoid and maxillary sinus mucosal thickening (3), white matter lesions (2), mega cisterna magna (2), sinusitis (1), chronic ischemic leukoencephalopathy (1), < 5 mm engagement of cerebellar tonsils into the foramen magnum (1), subcutaneous sebaceous cyst (1), aneurysm of basilar artery (1) and occipital bone exostoses (1). The second most common investigation was electrocardiogram (ECG) performed in 31 (12.7%) patients with no correlation with vital signs. All ECGs were reported as non-pathological. Finally, 16 (6.6%) patients underwent other investigations besides head CT and ECG: supra-aortic trunk echo-doppler (8), sinus CT scan (3), brain magnetic resonance imaging (MRI) (2), cervical X-rays (2) and electroencephalogram (1).

Table 3
Interventions in the emergency department
Investigations
 
head CT
183 (75.0)
ECG
31 (12.7)
other
16 (6.6)
Specialist consultations
 
neurologist
47 (19.3)
ophthalmologist
7 (2.9)
otolaryngologist
5 (2.0)
psychiatrist
5 (2.0)
cardiologist
2 (0.8)
neurosurgeon
2 (0.8)
Treatment administered
 
none
105 (43.0)
NSAIDs
108 (44.3)
weak opioids
43 (17.6)
antiemetics
31 (12.7)
PPIs
25 (10.2)
paracetamol
20 (8.2)
corticosteroids
16 (6.6)
anxiolitics
12 (4.9)
antibiotics
2 (0.8)
Classes of drugs (in ED)
 
one
61 (25.0)
two
45 (18.4)
three
24 (9.8)
four
7 (2.9)
five
2 (0.8)
CT: computed tomography; ECG: electrocardiogram; ED: emergency department; NSAIDs: non-steroidal anti-inflammatory drugs; PPIs: proton pump inhibitors

Specialist consultations received in the emergency department

Most patients were managed by ED physicians without the need for specialist consultation (Table 3). Of the total population of 244 patients, 47 (19.3%) were visited by a neurologist, 7 (2.9%) by an ophthalmologist, 5 (2.0%) by an otolaryngologist, 5 (2.0%) by a psychiatrist, 2 (0.8%) by a cardiologist and 2 (0.8%) by a neurosurgeon.

Headache treatment received in the emergency department

The pharmacological treatments administered in ED are summarized in Table 3. NSAIDs and weak opioids were the most commonly prescribed pharmacological agents, being administered in 44.3% and 17.6%. of patients, respectively. None of the 244 patients received a triptan. Treatment for associated symptoms included antiemetics and anxiolytics, administered to 12.7% and 4.9% of patients, respectively. Proton pump inhibitors were administered to 10.2% of patients. About 43% of patients did not receive any pharmacological treatment while among those who were treated 25% received monotherapy, and 18.4% and 9.8% received a combination of two or three pharmacological agents, respectively.

Triage and stay information in the emergency department

Stay information in ED of the 244 patients are summarized in Table 4. The median door-to-doctor time was 139 (range: 3-881), the median time of care (since the first contact with the ED to the time of discharge) was 241 minutes (range: 1-1404) and the mean time of permanence (since the arrival in the ED to the time of discharge) was 381 minutes (range: 20-2212). There was no significant correlation between the length of stay in ED and a number of factors (time of arrival in ED, triage coding, compliant of aura, blood pressure, head CT scan, ECG, other investigations and treatments’ administration). Conversely, the longer stay length in ED was significantly associated with the complaint of the first aura ever (p = 0.014) and if patients received neurological consultation (p < 0.001) or other specialist visits (p = 0.001).

Table 4
Factors that influence the length of stay in the emergency department
LENGTH OF STAY IN ENERGENCY DEPARTMENT
TIME OF ARRIVAL
mean
min
max
SD
p-value
08:00–15:59
381
20
2212
327
NS
16:00–23:59
393
37
1540
277
00:00–07:59
321
72
740
211
TRIAGE
mean
min
max
SD
p-value
white
320
320
320
.
NS
green
380
20
1540
282
yellow
387
37
2212
373
red
202
202
202
.
AURA
mean
min
max
SD
p-value
NO
368
20
2212
291
NS
SI
446
37
1412
360
FIRST AURA
mean
min
max
SD
p-value
NO
527
133
1412
376
0.014
SI
325
37
1386
306
SBP ≥ 140 mmHg
mean
min
max
SD
p-value
NO
383
20
2212
304
NS
SI
373
37
1529
306
DBP ≥ 90 mmHg
mean
min
max
SD
p-value
NO
389
20
2212
312
NS
SI
271
92
479
114
HEAD CT
mean
min
max
SD
p-value
NO
349
20
1540
270
NS
SI
391
37
2212
314
ECG
mean
min
max
SD
p-value
NO
359
20
1540
260
NS
SI
531
37
2212
492
OTHER INVESTIFGATIONS
mean
min
max
SD
p-value
NO
372
20
2212
294
NS
SI
510
37
1386
413
NEUROLOGICAL CONSULTATION
mean
min
max
SD
p-value
NO
333
20
2212
252
< 0.001
SI
580
37
1533
408
OTHER CONSULTATIONS
mean
min
max
SD
p-value
NO
359
20
2212
279
0.001
SI
625
115
1533
447
TREATMENT
mean
min
max
SD
p-value
NO
385
41
1529
303
NS
SI
377
20
2212
305
CT: computed tomography; DBP: diastolic blood pressure; SBP: systolic blood pressure; SD: standard deviation

Discharge

Discharge information are summarized in Table 5. At the time of discharge from ED the headache had not disappeared in 62.7% of the 244 patients and 43.9% of the patients had been discharged without a prescription. The most commonly prescribed drugs for headache treatments were NSAIDs and paracetamol, administered to 33.2% and 11.1% of patients, respectively, while triptans were prescribed only to 1.6%. Monotherapy was prescribed more frequently than combination therapy with two agents (44.7%% vs 10.2%). Only 5.8% of patients were prescribed prophylactic treatment on discharge. The most common post-discharge investigation was brain MRI that was prescribed to 4.1% of patients, while no further investigation was requested in 92.6% of patients.

Table 5
Discharge from the emergency department
Headache at discharge
 
no
153 (62.7)
yes
91 (37.3)
Drugs prescription
 
none
107 (43.9)
NSAIDs
81 (33.2)
paracetamol
27 (11.1)
week opioids
19 (7.8)
prevention
14 (5.8)
corticosteroids
5 (2.0)
triptans
4 (1.6)
anxiolitics
2 (0.8)
antiemetics
1 (0.4)
antibiotics
1 (0.4)
Classes of drugs (at discharge)
 
one
109 (44.7)
two
25 (10.2)
three
3 (1.2)
Post-discharge investigations
 
brain MRI + angio-MRI
12 (4.8)
EEG
2 (0.8)
psychiatric visit
2 (0.8)
Holter blood pressure
2 (0.8)
EEG: electroencephalogram; MRI: magnetic resonance imaging; NSAIDs: non-steroidal anti-inflammatory drugs

Follow-up in the headache centre

Information on follow-up visit in the headache centre are summarized in Table 6. The mean time to follow-up at our headache centre was 8.9 days (range: 1–30) after visiting the ED and 4 (1.6%) patients did not show up at the appointment. Considering the all sample of 244 patients, 97.5% were new patients and 2.5% were already followed in our headache clinic. All the 240 patients who attended the follow-up appointment at our clinic had their headache diagnosed according to the ICHD [2, 19]. Most patients (66.7%) were already aware of their diagnosis. A primary form of headache was diagnosed in 90% of patients, while a secondary headache was diagnosed in 10%. The three most common primary headache diagnosis were migraine without aura (53.3%), chronic migraine (CM) (14.6%) and migraine without aura (14.2%). The three most common diagnoses of secondary headache were medication overuse headache (MOH) (12.7%), headache attributed to trauma (3.3%) and headache attributed to cranial and/or cervical vascular disorder (2.5%). A double diagnosis was given to 24.6% and a triple diagnosis to 1.2% of the patients. The most frequent combinations of two diagnoses were CM and MOH (11.7%) followed by migraine with aura and migraine without aura (9.6%). The most frequent combination of three diagnoses was CM, MOH and migraine with aura (0.8%) followed by CM, MOH and headache attributed to cranial and/or cervical vascular disorder (0.4%). The average age at the onset of their headache was 25 years (range: 6–89) and 45% had a family history of migraine. Patients were managed according to their headache diagnosis. All patients with a new migraine diagnosis were prescribed specific acute treatment for migraine (e.g., triptans), where not contraindicated. To those patients with a known migraine diagnosis who had already encountered efficacy and/or tolerability problems with the triptan they had already used, another molecule belonging to the class of triptans and/or analgesic combination (e.g., paracetamol plus caffeine or codeine) was prescribed. Both patients with migraine and tension-type headache with > 4 attacks per month received oral prevention treatments according to international guidelines [20]. Regarding CM prevention, 24 (68.6%) of 35 patients with this diagnosis were prescribed quarterly injections of onabotulinumtoxinA [21, 22] and 26 (83.9%) of 31 patients with MOH began an in-patient withdrawal and rehabilitation protocol [23].

Table 6
Follow-up in the headache centre
Age at the onset (years) (SD)
25 (18.1)
New patient to our headache clinic
238 (97.5)
Days since discarge
8.9 (7.2)
Familiarity for headache (yes)
108 (45.0)
Aware of their diagnosis (yes)
160 (66.7)
Headache days per month
12.6 (9.5)
OnabotulinumtoxinA for CM
24 of 35 (68.6)
Rehabilitation for MOH
26 0f 31 (83.9)
CM: chronic migraine; MOH: medication overuse headache; SD: standard deviation

Discussion

We conducted a prospective study of a consecutive sample of 244 patients observed in our tertiary level headache centre after direct referral from our hospital’s ED where they presented with a chief compliant of headache. Our aim was to analyzed the different steps of the ED management of patients with headache to detect those deficiencies that can be overcome by a prompt referral to a headache clinic.

The first step of this journey is represented by the need to make the correct diagnosis. The evaluation of patients with headache in the ED environment presents significant differences compared to the evaluation of patients with headache in the clinic. The management of headache in an acute environment should focus on the exclusion of serious secondary causes, on the correct diagnosis, on the management of symptoms and possibly on establishing a continuing care plan [24]. The sense of urgency to rule out secondary and often life-threatening causes of headache, also due to of time constraints due to the need for efficient patient management, can lead ED physicians to interrupt the diagnosis process on the differential diagnosis between primary and secondary headache. Furthermore, a Canadian study to evaluate the diagnostic accuracy of neurological complaints in ED found that in 35.7% of cases the initial ED diagnosis was not in accordance with the final diagnosis possibly made by a neurologist; among the most common problems diagnosed incorrectly was primary headache [25]. There was a high discrepancy rate between the diagnosis made in our headache centre and that made in ED. This discrepancy can have several reasons. ED physicians may be more interested in ruling out serious causes of headache than in distinguishing different primary headaches or they may simply not be familiar with the ICHD diagnostic criteria. However, despite being aware of the diagnostic criteria, ED physicians may not have mattered because they intended to use the same treatment regardless of the diagnosis of primary headache. In addition, there is a possibility that ED physicians may simply accept the diagnosis of a triage nurse or that they may not change the diagnosis already entered in the system. However, the interesting finding was that ED physicians used only four diagnostic categories while triage nurses used eleven different diagnosis and the analyses of concordance among the three different diagnoses (triage, ED physician and headache centre) shown a significant moderate agreement only for the diagnosis of migraine and only between triage and headache centre.

The second step of the journey is the diagnostic investigations that may be necessary to confirm the diagnostic intuition and establish consistent treatment. Head CT is commonly used to evaluate headache due to its prompt accessibility and diagnostic accuracy, but unnecessary head CT scans lead to a longer duration of ED stay [26], exposure to radiations [27] and increased medical costs [28]. The use of CT for non-traumatic headache in the US emergency departments has doubled in the past 20 years. A recent study showed that up to 31% of patients who had headache underwent imaging [11, 29] and head CTs accounted for almost the 50% all CTs performed in United States ED visits [30]. However, of the CT scans performed in the United States EDs among patients with headache between 1992 and 2001, almost 95% showed no pathology [11]. We found that 75% of the patients who attended our ED with a major compliant of headache underwent CT scan which in 93.4% of the cases was negative while in the other cases it showed results all considered accidental and not potentially lethal (Table 3). However, this large use of CT in the ED requires serious reflection. In fact, a recent study found that a 9.6% decrease in the use of head CT for patients who come to ED with a chief complaint of headache was not followed by an increase in death or missed diagnoses [31], adding to the convincing evidence that there is a possibility to safely decrease CT scan for ED patients. In contrast, in support of CT use, another study found that patients who underwent a CT scan of the head during an initial ED visit were about half as likely to return to ED within 30 days than those weren’t underwent CT [32]. Cranial imaging has been shown to have a positive influence on patients’ fear and anxiety levels [33] and, reassuring patients, CT scan prevent return ED visits. However, we can speculate that a rapid referral to a headache unit may have, at least in some patients, a similar reassuring effect but avoiding the impact of CT on the patient and the healthcare system.

The third step is the request for specialist consultations aimed at adding experience to the work of ED physicians. In our ED at least one neurologist is available 24hours a day, 7 days a week, both for first-line evaluation if the pre-hospital evaluation suggests a neurological condition, and for the second-line, according to the judgement of a non-neurologist ED physician at the arrival of the patient. However, less than a fifth (19.3%) of the patients received a neurological consultation (Table 3). This rate was lower than that found in another study conducted in French EDs in which a third of patients received a consultation with a neurologist [8]. The authors speculated that this may have been due to the fact that patients were experiencing an unusually severe attack or because a differential diagnosis was deemed necessary for patients who had reported a first episode of headache. We can assume that the lower rate of consultations in our study may have several reasons and, among these, the doctor’s certainty of excluding a secondary headache and the knowledge of the possibility of a rapid referral to our headache clinic. Further consultations were requested for 8.2% of the patients and the three most frequently consulted specialists were ophthalmologists (for the aura), otolaryngologists (for sinusitis) and psychiatrists (for comorbid conditions). However, having received specialist consultations, both neurological and other, was the only factor, together with the complaint of the first aura in life, to be significantly associated with a longer stay in ED (Table 4). It is possible that in front of a patient who reported having previously had other episodes of aura, the ED doctor was reassured on the benignity of the symptom while in the case of the first aura the doctor had a more cautious attitude and preferred to seek advice. this fact could also indicate an inadequate knowledge of the diagnostic criteria of primary headaches in general, and specifically of the clinical spectrum of migraine.

The fourth and fundamental step in the management of headache in ED is pharmacological treatment. Patients presenting with migraine or other headaches have the third highest self-reported pain scores among all patients presenting to ED with a painful condition [34]. Consistently, the American Migraine Prevalence and Prevention (AMPP) study found that unbearable pain was the patients’ most common reason for using ED for migraine [35]. Patients attending ED with a headache pattern similar to previous migraine attacks generally do not require, or either want, diagnostic tests, but expect rapid and effective management of their headache and any incorrect diagnosis can lead to a generalized pain treatment rather than of migraine-specific treatment [17]. More than 20 different drugs and drug combinations are used to treat migraine in ED, including migraine-specific drugs (e.g., sumatriptan and dihydroergotamine), dopamine antagonists (e.g., metoclopramide, chlorpromazine and prochlorperazine), NSAIDs, opioids, corticosteroids, and anti-histamines (e.g., diphenhydramine and promethazine) [36]. In our ED, the most commonly prescribed pharmacological agents were NSAIDs and weak opioids, administered in 44.3% and 17.6%. of patients, respectively, followed by paracetamol which was administered to 8.2% of patients (Table 3). Treatment for associated symptoms included antiemetics and anxiolytics, administered to 12.7% and 4.9% of patients, respectively. Another study conducted in Europe showed an opposite use of NSAIDs (42.9%) and non-opioid analgesics (61.2%) and a lower use of antiemetics (8%) and anxiolytics (3%) [8]. In the study mentioned above, approximately 9% of patients did not receive any pharmacological treatment and triptans were not administered as frequently (11.2%) [8]. In our sample, approximately 43% of patients did not receive any drugs and no patients received triptans (or ergotamines). However, the limited use of triptans in ED is not limited to European countries. A survey conducted in a United States ED found an equally high percentage of patients (38%) who received neither drugs nor intravenous fluids [17]. Significant variations exist in managing headache between and within EDs due to lack of strong recommendations, physician comfort and familiarity with specific medications, beliefs about efficacy, concern about short-term side effects and patient request [3638]. Only recently, the Canadian Headache Society and the American Headache Society provided evidence-based therapeutic recommendations for migraine that require treatment in emergency settings [39, 40].

The fifth and final step in the management headache in ED is represented by discharge. Significant evidence suggests that migraine discharge management is often suboptimal. About 40% of emergency physicians never prescribed triptans at discharge [41], approximately 60% of patients had no documented discharge medications and 2/3 of patients did not receive a physician follow-up recommendation [17]. These malpractices contribute to the high rate of return visits to ED noted among migraine patients [42]. Another study found a high percentage of patients (34.7%) discharged without a prescription and also in this case the most commonly prescribed drugs were analgesics and NSAIDs rather than migraine-specific drugs [8]. Our data, in line with the previous literature, shown that 43.9% of patients were discharged without a prescription while the most commonly prescribed drugs for headache treatments were analgesics NSAIDs (33.2) and paracetamol (11.1%) while triptans were prescribed only to 1.6% (Table 5).

Considering what has been previously discussed about the journey through ED of a patient complaining of headache, a fast track between ED and a headache clinic represents a step forward in managing headache. Headache is the most common disorder among patients presenting to ED with neurological complaints [43] and although in most cases it is discharged as non-urgent complaint, those patients feel they need urgent medical evaluation [44]. In contrast, migraine patients, especially those with a known diagnosis, should have an idea that their headache is not a life-threatening condition and if they get to ED it is more because of access issues and less because of a perceived need for emergent treatment. Inappropriate ED utilization causes overcrowding and consequently an increase in intervention times, which is one of the main reasons for leaving ED to prematurely [45], especially among patients with headache compliant [46]. This suggests that a healthcare system could reduce ED visits among migraine patients by increasing the availability of urgent care or walk-in appointments [47].

Another proof of the importance of rapid referral to a headache centre comes from an analysis of the use of ED by patients with migraine. The AMPP study showed that only a small subset of respondents used ED to treat severe headaches in the previous 12 months: 3% visited the ED once and another 3% visited ED more than once [35]. Interestingly, in a previous study, we showed that among 548 migraine patients who attended our headache clinic and who were in continuous treatment and underwent regular follow-up visits, only 0.9% of them entered the ED during the entire 2-years observation period [48]. This finding is explained by the fact that migraine prevention and prescription of migraine-specific rescue therapies reduce resource use in general, and in particular ED visits [4951]. In addition to improving the health and quality of life of patients, a preferential between ED and the headache clinic can lead to significant economic savings considering that ED care is considerably more expensive than both hospital outpatient care and office-based outpatient care. In a time characterized by economic difficulties and the availability of new and expenses treatments, such as the monoclonal antibodies targeting the calcitonin gene-related peptide, a virtuous allocation of economic resources becomes mandatory [52].

Limitations

The study has several potential limitations. First of all, there are intrinsic limitations related to the use of data collected mainly for clinical care, such as errors in the registration of some information that could be perceived of secondary importance in the particular setting of ED. However, we believe the variables of primary interest in this analysis, including socio-demographic characteristics, diagnostic procedures, specialist consultations and drugs should not have been subjected to inaccurate recording. Second, the enrollment period was between January 1, 2015 and December 31, 2018 and, for this reason, most patients were diagnosed according to the beta version of the ICHD-III published in 2013 while the definitive version was published in early 2018. Third, the decision of ED physicians to refer or not a patient discharged from the ED for a major compliant of headache to our headache centre is totally personal and independent. As a result, there is a possibility that patients have been primarily referred by some physicians and not others and that it may introduce a selection bias towards a certain type of patient rather than another. Finally, this study was conducted in a single university hospital for tertiary care and our results may not be generalized to other countries or even to other Italian regions or to other EDs that could have different organizational and therapeutic protocols.

Conclusions

The great majority of patients who went to the emergency room complaining of headache received the same therapy regardless of the cause of the headache and for this reason in many cases the headache had not yet resolved at the time of discharge. We showed a high rate of misdiagnosis of primary headaches and a short track between ED and the headache center is of primary importance to help the patient obtain a definite diagnosis and adequate treatment. Reducing the number of emergency visits for primary headaches, and in particular migraine, is the goal and an easy and rapid referral to headache specialists can prevent further recourse to ED. In addition, an implementation of referral from ED to the headache center of the same hospital, if any, can increase the quality of management of headache patients and, due to shared information on the hospital’s EMRs, may avoid the need to repeat diagnostic investigations and reduce time and expenses, thus leading to better allocation of public resources.

Abbreviations

BP: blood pressure; CGRP: calcitonin gene-related peptide; CM: chronic migraine; CT: computed tomography; ECG: electrocardiogram; ED: Emergency department; EEG: electroencephalogram; EM: episodic migraine; EMR: electronic medical records; ICHD: International classification of headache disorders; MOH: medication overuse headache; MRI: magnetic resonance imaging; NSAIDs: non-steroidal anti-inflammatory drugs; TACs: trigeminal autonomic cephalalgias

Declarations

Ethics approval and consent to participate

Study protocol was submitted to the Ethics Committee.

Consent for publication

Not applicable.

Availability of data and material

Dataset available from the corresponding author on reasonable request

Competing interests

A. Negro received travel grants, consulting fees and speaking fees from Allergan, Eli Lilly, Novartis, and TEVA.

P. Martelletti received travel grants, consulting fees and speaking fees from Allergan, Amgen, Eli Lilly, Novartis, and TEVA.

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed.

Funding

This paper was not funded.

Authors’ contributions

AN: study design, data acquisition, data analysis and interpretation, drafting the manuscript.

VS: study design, data acquisition.

PS: statistical analysis.

PM: conception of the study and revising the manuscript critically.

All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

ORCID

Andrea Negro        http://orcid.org/0000-0003-3590-298X

Valerio Spuntarelli    http://orcid.org/0000-0003-1591-7003

Paolo Sciattella      https://orcid.org/0000-0002-8364-1895

Paolo Martelletti    http://orcid.org/0000-0002-6556-4128

References

  1. Evans RW, Friedman BW. Headache in the emergency department. Headache. 2011;51(8):1276-78.
  2. Headache classification committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
  3. GBD 2016 Disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211-59.
  4. Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010;52(1):8-14.
  5. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301-15.
  6. Cerbo R, Villani V, Bruti G, Di Stani F, Mostardini C. Primary headache in Emergency Department: prevalence, clinical features and therapeutical approach. J Headache Pain. 2005;6(4):287-9.
  7. Friedman BW, Hochberg ML, Esses D, Grosberg B, Corbo J, Toosi B, Meyer RH, Bijur PE, Lipton RB, Gallagher EJ. Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation. Ann Emerg Med. 2007;49(4):409-19, 419.e1-9.
  8. Valade D, Lucas C, Calvel L, Plaisance P, Derouet N, Meric G, Lanteri-Minet M, Giroud M. Migraine diagnosis and management in general emergency departments in France. Cephalalgia. 2011 Mar;31(4):471-80.
  9. Munoz-Ceron J, Marin-Careaga V, Peña L, Mutis J, Ortiz G. Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags. PLoS One. 2019;14(1):e0208728.
  10. Doretti A, Shestaritc I, Ungaro D, Lee JI, Lymperopoulos L, Kokoti L, Guglielmetti M, Mitsikostas DD, Lampl C; School of Advanced Studies of the European Headache Federation (EHF-SAS). Headaches in the emergency department -a survey of patients' characteristics, facts and needs.J Headache Pain. 2019;20(1):100.
  11. Goldstein JN, Camargo CA Jr, Pelletier AJ, Edlow JA. Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses. Cephalalgia. 2006;26(6):684-90.
  12. Locker TE, Thompson C, Rylance J, Mason SM. The utility of clinical features in patients presenting with nontraumatic headache: an investigation of adult patients attending an emergency department. Headache. 2006;46(6):954-61.
  13. Sempere-Selva T, Peiró S, Sendra-Pina P, Martínez-Espín C, López-Aguilera I. Inappropriate use of an accident and emergency department: magnitude, associated factors, and reasons--an approach with explicit criteria. Ann Emerg Med. 2001;37(6):568-79.
  14. Miyazawa A, Maeno T, Shaku F, Tsutsumi M, Kurihara H, Takayashiki A, Kohno M, Suzuki M, Maeno T. Inappropriate use of the emergency department for nonurgent conditions: Patient characteristics and associated factors at a Japanese hospital. J Gen Fam Med. 2019;20(4):146-153.
  15. Minen MT, Loder E, Friedman B. Factors associated with emergency department visits for migraine: an observational study. Headache. 2014;54(10):1611-8.
  16. Blumenthal HJ1, Weisz MA, Kelly KM, Mayer RL, Blonsky J. Treatment of primary headache in the emergency department. Headache. 2003;43(10):1026-31.
  17. Gupta MX, Silberstein SD, Young WB, Hopkins M, Lopez BL, Samsa GP. Less is not more: underutilization of headache medications in a university hospital emergency department. Headache. 2007;47(8):1125-33.
  18. Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, Miller EPR 3rd, Polonsky T, Thompson-Paul AM, Vupputuri S. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2018;71(6):e116-e135.
  19. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808.
  20. Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults. Neurology. 2012;78:1337-45.
  21. Negro A, D’Alonzo L, Lala N, Martelletti P. A 2-year prospective evaluation study on onabotulinumtoxinA 155 U in chronic migraine. SpringerPlus. 2015; 4:826.
  22. Negro A, Curto M, Lionetto L, Martelletti P. A two years open-label prospective study of onabotulinumtoxinA 195 U in medication overuse headache: a real-world experience. J Headache Pain 2016;17:1.
  23. Negro A, Curto M, Lionetto L, Guerzoni S, Pini LA, Martelletti P. A critical evaluation on MOH current treatments. Curr Treat Options Neurol. 2017;19(9):32.
  24. Ward TN, Levin M, Phillips JM. Evaluation and management of headache in the emergency department. Med Clin North Am. 2001;85(4):971-85.
  25. Moeller JJ, Kurniawan J, Gubitz GJ, Ross JA, Bhan V. Diagnostic accuracy of neurological problems in the emergency department. Can J Neurol Sci. 2008;35(3):335-41.
  26. Kerber KA, Schweigler L, West BT, Fendrick AM, Morgenstern LB. Value of computed tomography scans in ED dizziness visits: analysis from a nationally representative sample. Am J Emerg Med. 2010;28(9):1030-6.
  27. Colang JE, Killion JB, Vano E. Patient dose from CT: a literature review. Radiol Technol. 2007;79(1):17-26.
  28. Wang X, You JJ. Head CT for nontrauma patients in the emergency department: clinical predictors of abnormal findings. Radiology. 2013;266(3):783-90.
  29. Gilbert JW, Johnson KM, Larkin GL, Moore CL. Atraumatic headache in US emergency departments: recent trends in CT/MRI utilisation and factors associated with severe intracranial pathology. Emerg Med J. 2012;29(7):576-81.
  30. Centers for Disease Control and Prevention. National ambulatory medical care survey: 2010 summary tables. Available at: https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. Accessed December 15, 2019.
  31. Miller DG, Vakkalanka P, Moubarek ML, Lee S, Mohr NM. Reduced Computed Tomography Use in the Emergency Department Evaluation of Headache Was Not Followed by Increased Death or Missed Diagnosis. West J Emerg Med. 2018;19(2):319-326.
  32. Patterson BW, Pang PS, AlKhawam L, Hamedani AG, Mendonca EA, Zhao YQ, Venkatesh AK. The Association Between Use of Brain CT for Atraumatic Headache and 30-Day Emergency Department Revisitation. AJR Am J Roentgenol. 2016;207(6):W117-W124.
  33. Howard L, Wessely S, Leese M, Page L, McCrone P, Husain K, Tong J, Dowson A. Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache. J Neurol Neurosurg Psychiatry. 2005;76(11):1558-64.
  34. Lucado J, Paez K, Elixhauser A. Headaches in U.S. Hospitals and Emergency Departments, 2008: Statistical Brief #111. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-2011 May.
  35. Friedman BW, Serrano D, Reed M, Diamond M, Lipton RB. Use of the emergency department for severe headache. A population-based study. Headache. 2009;49(1):21-30.
  36. Friedman BW, West J, Vinson DR, Minen MT, Restivo A, Gallagher EJ. Current management of migraine in US emergency departments: an analysis of the National Hospital Ambulatory Medical Care Survey. Cephalalgia. 2015;35(4):301-9.
  37. Acute headache management in Emergency Department. A narrative review. Giamberardino MA, Affaitati G, Costantini R, Guglielmetti M, Martelletti P. Int Emerg Med 2019; 14: 000-000 accepted for publication httpps://doi.org/ 1007/s11739-019-02266-2
  38. Vinson DR, Hurtado TR, Vandenberg JT, Banwart L. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med. 2003;41(1):90-7.
  39. Orr SL, Aubé M, Becker WJ, Davenport WJ, Dilli E, Dodick D, Giammarco R, Gladstone J, Leroux E, Pim H, Dickinson G, Christie SN. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015;35(3):271-84.
  40. Orr SL, FriedmanBW, Christie S, et al. Management of adults with acute migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache 2016;56:911-40.
  41. Nijjar SS, Pink L, Gordon AS. Examination of migraine management in emergency departments. Pain Res Manag. 2011;16(3):183-6.
  42. Maizels M. Health resource utilization of the emergency department headache "repeater". Headache. 2002;42(8):747-53.
  43. Royl G, Ploner CJ, Möckel M, Leithner C. Neurological chief complaints in an emergency room. Nervenarzt. 2010;81(10):1226-30.
  44. Harenberg L, Oßwald HM, Jaschonek H, Nagel S. Self-assessment of treatment urgency on presentation to a neurological emergency department: Results of a patient survey. Nervenarzt. 2019;90(2):175-182.
  45. van der Linden MC, Lindeboom R, van der Linden N, van den Brand CL, Lam RC, Lucas C, Rhemrev SJ, de Haan R, Goslings JC. Walkouts from the emergency department: characteristics, reasons and medical care needs. Eur J Emerg Med. 2014;21(5):354-9.
  46. Hoyer C, Stein P, Alonso A, Platten M, Szabo K. Uncompleted emergency department care and discharge against medical advice in patients with neurological complaints: a chart review. BMC Emerg Med. 2019;19(1):52.
  47. Pellesi L, Benemei S, Favoni V, Lupi C, Mampreso E, Negro A, Paolucci M, Steiner TJ, Ulivi M, Cevoli S, Guerzoni S. Quality indicators in headache care: an implementation study in six Italian specialist-care centres. J Headache Pain. 2017;18(1):55.
  48. Negro A, Sciattella P, Rossi D, Guglielmetti M, Martelletti P, Mennini FS. Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre. https://doi.org/10.1186/s10194-019-1068-y
  49. Lofland JH, Kim SS, Batenhorst AS, Johnson NE, Chatterton ML, Cady RK, Kaniecki R, Nash DB. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine. Mayo Clin Proc. 2001;76(11):1093-101.
  50. Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medication reduces resource utilization. Headache. 2003;43(3):171-8.
  51. Láinez MJ. The effect of migraine prophylaxis on migraine-related resource use and productivity. CNS Drugs. 2009;23(9):727-38.
  52. Negro A, Martelletti P. Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies. Expert Rev Neurother. 2019;29:1-8.